Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccination in Prevention From Coronary Events in Patients With Coronary Artery Disease
NCT00371098Phase 3Completed
- Sponsor
- National Institute of Cardiology
- Start
- Oct 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of influenza vaccine in coronary artery disease (CAD) (2 arms), sponsored by National Institute of Cardiology. Primary endpoint: Cardiovascular death at 12 months. Started Oct 2004; status: completed.
02
Drugs
influenza vaccine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00371098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371098.